EXECUTIVE SUMMARY FOR EXPERT REVIEWERS [2]

DOCUMENT A.4 — OPERATIONAL CONCEPT SET [2]
Nguyen Dinh Quang — Vien gut Model [2]
March 2026 — Ho Chi Minh City, Vietnam [2]

1. Purpose and Compiling Principles [2, 5]

A.4 is the central reference document: any international reviewer encountering a HOW term in any document from A.0 to C.4 can consult A.4 to find an accurate, consistent definition with international cross-references [2]. A total of 35 terms, categorized into 3 groups by origin [2, 5]:

Group Group Name Characteristics [5]
A Existing international terms (7) Uses correct international definitions, applied to LMIC multimorbidity [5]
B Equivalent meaning terms (18) Has equivalent concepts; Vien gut provides more specific operational interpretations [5]
C Vien gut-developed terms (35 total) Developed from 18 years of practice — no equivalent in existing literature [5]

Three compiling rules: (1) Transparency of origin; (2) Operational definition; (3) International comparison [5].

2. Group A — Existing International Terms [6]

7 core terms: Treat-to-target (T2T), Crystal-free, Multimorbidity, Risk stratification, Integrated care, Chronic Care Model (CCM), Real-World Evidence (RWE). Vien gut does not change the meaning, only applies them to the context of complex chronic multimorbidity in LMICs [6]. Notable point: T2T is extended and applied simultaneously across four axes (gout, kidney, heart, liver); integrated multi-axial risk stratification (T1–T4) instead of individual diseases [6].

3. Group B — Equivalent Terms or Different Interpretations [7, 8]
Vien gut Term International Comparison and Differences [7, 8]
HOW gap Closest: WHO ‘know-do gap’, Implementation Science ‘implementation gap’. VG emphasizes: lack of operational structure, not lack of motivation or knowledge [7].
Clinical Conductor Closest: CCM ‘care coordinator’, WHO ‘case manager’. VG emphasizes: proactive coordination, decision-making authority for cross-guideline priorities, SLA 24–48h [7].
DATA-to-operate Closest: ‘actionable data’, ‘decision-relevant data’. VG distinguishes: not research data or EMR — but data that triggers immediate clinical decisions [8].
Monitoring SLA SLA from ITIL service management. VG transferred into chronic outpatient care: 4 levels (4h/12h/24h/48h), not yet in outpatient literature [8].
Phased treatment plan Closest: ‘phased treatment’ in oncology. VG expands: 4 phases across four simultaneous multimorbidity axes [8].
4. Group C — Vien gut Developed Terms [9-11]
Term Summary Operational Definition [9-11]
Clinical blind zone Areas where patients need treatment but are not covered by guidelines — because evidence was designed for a different reference frame [9].
Double blind zone Two guidelines for two comorbidities are both silent on the intersection — the deepest blind zone [9].
Guideline paradox Doing the right thing for each individual disease guideline but being collectively wrong for the multimorbidity patient — due to a shift in the reference frame [9].
Referral safety valve Pre-defined clinical thresholds that trigger referral according to SLA — without waiting for the next visit [9].
Clinical priority map A tool to determine priority order when single-disease guidelines conflict for the same patient [10].
Window of opportunity (operational) Longitudinal monitoring state: 4 layers (outpatient safety / HOW implementation / DATA sufficiency / outcome anchor). Assessment: still open / closing / closed [10].
Sensor–response system Continuously operating MDT: each component both senses and responds, with 7 operational chain roles [10].
Caliper mm² Measuring urate crystals with digital calipers (mm²) — developed 9 years before OMERACT 0–3 [10].
Conflict resolution matrix Matrix tool to support adjudication when guidelines have opposing requirements for the same patient [10].
Visual Medicine Standardized clinical images/videos = operational data + compliance tools + verifiable evidence [11].

Strategic Argument: Clinical blind zones exist not because medicine lacks evidence — but because evidence is generated in a reference frame different from the reality of complex patients. Vien gut builds a new reference frame: blind zone mapping + integrated outpatient operational layer — shifting from ‘individual capacity-dependent treatment’ to ‘treatment based on structured system capacity, data, and safety valves’ [11].

5. Position in the Document System [12]

A.4 is the central reference for the entire document set A.0–C.4. Main links: A.1 (EBM framework), A.2 (three-layer definition), A.3 (gap evidence), B.1–B.5 (operations), and C.1–C.4 (verification targets). A.5 (standardized glossary) adds a bilingual quick-reference table [12].

REFERENCES (abridged) [12, 13]

FitzGerald JD, et al. 2020 ACR Guideline for Gout [12].
Richette P, et al. 2016 EULAR recommendations for gout [12].
WHO. Framework on Integrated, People-centred Health Services. 2016 [13].
Barnett K, et al. Epidemiology of multimorbidity. Lancet. 2012 [13].
Wagner EH, et al. Improving chronic illness care. 2001 [13].
Eccles MP, Mittman BS. Welcome to Implementation Science. 2006 [13].
Tinetti ME, et al. Pitfalls of disease-specific guidelines. NEJM. 2004 [13].
Terslev L, et al. Ultrasound as outcome measure in gout — OMERACT. 2015 [13].

EXECUTIVE SUMMARY FOR EXPERT REVIEWERS [2]

DOCUMENT A.4 — OPERATIONAL CONCEPT SET [2]
Nguyen Dinh Quang — Vien gut Model [2]
March 2026 — Ho Chi Minh City, Vietnam [2]

1. Purpose and Compiling Principles [2, 5]

A.4 is the central reference document: any international reviewer encountering a HOW term in any document from A.0 to C.4 can consult A.4 to find an accurate, consistent definition with international cross-references [2]. A total of 35 terms, categorized into 3 groups by origin [2, 5]:

Group Group Name Characteristics [5]
A Existing international terms (7) Uses correct international definitions, applied to LMIC multimorbidity [5]
B Equivalent meaning terms (18) Has equivalent concepts; Vien gut provides more specific operational interpretations [5]
C Vien gut-developed terms (35 total) Developed from 18 years of practice — no equivalent in existing literature [5]

Three compiling rules: (1) Transparency of origin; (2) Operational definition; (3) International comparison [5].

2. Group A — Existing International Terms [6]

7 core terms: Treat-to-target (T2T), Crystal-free, Multimorbidity, Risk stratification, Integrated care, Chronic Care Model (CCM), Real-World Evidence (RWE). Vien gut does not change the meaning, only applies them to the context of complex chronic multimorbidity in LMICs [6]. Notable point: T2T is extended and applied simultaneously across four axes (gout, kidney, heart, liver); integrated multi-axial risk stratification (T1–T4) instead of individual diseases [6].

3. Group B — Equivalent Terms or Different Interpretations [7, 8]
Vien gut Term International Comparison and Differences [7, 8]
HOW gap Closest: WHO ‘know-do gap’, Implementation Science ‘implementation gap’. VG emphasizes: lack of operational structure, not lack of motivation or knowledge [7].
Clinical Conductor Closest: CCM ‘care coordinator’, WHO ‘case manager’. VG emphasizes: proactive coordination, decision-making authority for cross-guideline priorities, SLA 24–48h [7].
DATA-to-operate Closest: ‘actionable data’, ‘decision-relevant data’. VG distinguishes: not research data or EMR — but data that triggers immediate clinical decisions [8].
Monitoring SLA SLA from ITIL service management. VG transferred into chronic outpatient care: 4 levels (4h/12h/24h/48h), not yet in outpatient literature [8].
Phased treatment plan Closest: ‘phased treatment’ in oncology. VG expands: 4 phases across four simultaneous multimorbidity axes [8].
4. Group C — Vien gut Developed Terms [9-11]
Term Summary Operational Definition [9-11]
Clinical blind zone Areas where patients need treatment but are not covered by guidelines — because evidence was designed for a different reference frame [9].
Double blind zone Two guidelines for two comorbidities are both silent on the intersection — the deepest blind zone [9].
Guideline paradox Doing the right thing for each individual disease guideline but being collectively wrong for the multimorbidity patient — due to a shift in the reference frame [9].
Referral safety valve Pre-defined clinical thresholds that trigger referral according to SLA — without waiting for the next visit [9].
Clinical priority map A tool to determine priority order when single-disease guidelines conflict for the same patient [10].
Window of opportunity (operational) Longitudinal monitoring state: 4 layers (outpatient safety / HOW implementation / DATA sufficiency / outcome anchor). Assessment: still open / closing / closed [10].
Sensor–response system Continuously operating MDT: each component both senses and responds, with 7 operational chain roles [10].
Caliper mm² Measuring urate crystals with digital calipers (mm²) — developed 9 years before OMERACT 0–3 [10].
Conflict resolution matrix Matrix tool to support adjudication when guidelines have opposing requirements for the same patient [10].
Visual Medicine Standardized clinical images/videos = operational data + compliance tools + verifiable evidence [11].

Strategic Argument: Clinical blind zones exist not because medicine lacks evidence — but because evidence is generated in a reference frame different from the reality of complex patients. Vien gut builds a new reference frame: blind zone mapping + integrated outpatient operational layer — shifting from ‘individual capacity-dependent treatment’ to ‘treatment based on structured system capacity, data, and safety valves’ [11].

5. Position in the Document System [12]

A.4 is the central reference for the entire document set A.0–C.4. Main links: A.1 (EBM framework), A.2 (three-layer definition), A.3 (gap evidence), B.1–B.5 (operations), and C.1–C.4 (verification targets). A.5 (standardized glossary) adds a bilingual quick-reference table [12].

REFERENCES (abridged) [12, 13]

FitzGerald JD, et al. 2020 ACR Guideline for Gout [12].
Richette P, et al. 2016 EULAR recommendations for gout [12].
WHO. Framework on Integrated, People-centred Health Services. 2016 [13].
Barnett K, et al. Epidemiology of multimorbidity. Lancet. 2012 [13].
Wagner EH, et al. Improving chronic illness care. 2001 [13].
Eccles MP, Mittman BS. Welcome to Implementation Science. 2006 [13].
Tinetti ME, et al. Pitfalls of disease-specific guidelines. NEJM. 2004 [13].
Terslev L, et al. Ultrasound as outcome measure in gout — OMERACT. 2015 [13].